Largest health care biotech companies in the United States by market cap

Amgen leads the 20 health care biotech companies in the United States ranked by market value, at $236.9B, ahead of Gilead Sciences ($208.5B) and Moderna ($78.9B). Figures as of 20 Nov 2026, 19:04 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
20
First
Amgen$236.9B
Median
$10.2B
Combined market value
$733B
Countries
1

Market values as of .

United States
Health Care
Biotech
USD
Clear filters
Largest health care biotech companies in the United States by market cap
#CompanyMarket cap ↓PriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health Care$236.9B$438.00 0.39% up 30% up United States
2Gilead SciencesGILD · Health Care$208.5B$168.11 0.95% up 31% up United States
3ModernaMRNA · Health Care$78.9B$194.96 2.19% down 740% up United States
4BiogenBIIB · Health Care$37B$250.00 1.16% up 41% up United States
5Revolution MedicinesRVMD · Health Care$35.2B$162.74 2.08% up 125% up United States
6ExelixisEXEL · Health Care$16B$65.42 0.62% down 55% up United States
7Neurocrine BiosciencesNBIX · Health Care$15.5B$152.82 2.41% down 10% up United States
8Bio-TechneTECH · Health Care$11.4B$72.72 0.02% up 18% up United States
9RepligenRGEN · Health Care$10.6B$166.21 2.40% down 5% up United States
10Halozyme TherapeuticsHALO · Health Care$10.6B$92.85 0.20% down 32% up United States
11Kymera TherapeuticsKYMR · Health Care$9.9B$115.56 3.21% down 81% up United States
12Krystal BiotechKRYS · Health Care$9.3B$312.61 1.02% down 49% up United States
13VaxcytePCVX · Health Care$8.9B$56.46 3.26% down 22% up United States
14CG OncologyCGON · Health Care$7.2B$80.65 1.53% down 93% up United States
15Twist BioscienceTWST · Health Care$7.2B$105.25 5.71% down 291% up United States
16ImmunovantIMVT · Health Care$6.6B$32.07 1.38% down 44% up United States
17ImmunityBioIBRX · Health Care$6.5B$6.08 7.46% down 216% up United States
18Kodiak SciencesKOD · Health Care$6.4B$98.20 0.31% up 371% up United States
19Scholar Rock HoldingSRRK · Health Care$6B$48.98 2.77% down 25% up United States
20Adaptive BiotechnologiesADPT · Health Care$4.5B$28.01 0.14% down 51% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration.

Questions and answers

Which health care biotech companies in the United States rank first by market value?

Amgen ($236.9B), Gilead Sciences ($208.5B) and Moderna ($78.9B) are the top three of the 20 health care biotech companies in the United States ranked by market value as of 20 Nov 2026, 19:04 UTC.

How many health care biotech companies in the United States are in this ranking?

20 are ranked by market value.

What are these health care biotech companies in the United States worth together?

The 20 health care biotech companies in the United States ranked by market value have a combined market value of $733B as of 20 Nov 2026, 19:04 UTC.

What does ranking by market value measure?

What the stock market values the whole company at: its share price times the number of its shares.

Cite this page

Funkfolio, “Largest health care biotech companies in the United States by market cap”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&country=united-states

Underlying data: Yahoo Finance; SEC EDGAR.